Systems And Methods For Facilitating Diagnosis, Prognosis And Treatment Of Cancer Based On Detection Of Her3 Activation

  • Published: Feb 11, 2016
  • Earliest Priority: Apr 05 2013
  • Family: 8
  • Cited Works: 2
  • Cited by: 2
  • Cites: 3
  • Additional Info: Cited Works Full text
Abstract

Systems and methods are provided for facilitating diagnosis, prognosis and treatment of cancer based on detection of HER3 activation. The systems and methods involve analysis of samples for the presence or the absence of activated HER3 markers as indicated by HER2-HER3 heterodimers, HER3 phosphorylation, or recruitment of PI3K to activated HER3 (HER3/PI3K complexes). The amounts of activated HER3 marker expression may be measured alone or in conjunction with other biomarkers.


Claims
Download PDF
Document Preview
Document History
  • Publication: Feb 11, 2016
  • Application: Apr 7, 2014
    US US 201414781468 A
  • Priority: Apr 7, 2014
    US US 201414781468 A
  • Priority: Apr 7, 2014
    US US 2014/0033208 W
  • Priority: Apr 5, 2013
    US US 201361809083 P

Download Citation


Sign in to the Lens

Feedback